Enhance healthcare with advanced genomics
eVai platform enables precise and early diagnosis of Rare Disease ensuring unprecedented accuracy in interpreting genomic variants.
Guideline-based classification
Family Analysis & Variant Filtering
Continuous Learning
Disease-driven variant prioritization
Guideline-based classification
Family Analysis & Variant Filtering
Continuous Learning
Disease-driven variant prioritization
By combining artificial intelligence with ACMG, AMP and ClinGen guidelines, eVai classifies and prioritizes genomic variants by pathogenicity, suggesting the possible genetic diagnoses.
Our breakthrough AI technology goes beyond the “one-gene one-disease” paradigm unlocking new diagnoses through the assessment of the pathogenic variant combinations.
Some of our happy clients
Since 2011 our scientific team has been developing different bioinformatics workflows (DNA-Seq, RNA-Seq, Liquid Biopsy) for customers worldwide.
